Winston Pharmaceuticals, Inc.
WPHM
$0.00
$0.000.00%
OTC PK
| 03/31/2010 | 12/31/2009 | 09/30/2009 | 06/30/2009 | 03/31/2009 | |
|---|---|---|---|---|---|
| Revenue | 92.42% | 208.18% | 670.26% | 135.00% | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 92.42% | 208.18% | 670.26% | 135.00% | -- |
| Cost of Revenue | -39.55% | -40.99% | -29.24% | -23.43% | -- |
| Gross Profit | 79.80% | 78.04% | 65.93% | 47.55% | -- |
| SG&A Expenses | -16.14% | -5.40% | 21.80% | 45.31% | -- |
| Depreciation & Amortization | -5.38% | 1.12% | 16.25% | 45.45% | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -29.43% | -27.27% | -11.91% | -1.39% | -- |
| Operating Income | 48.10% | 47.63% | 35.12% | 14.84% | -- |
| Income Before Tax | 49.08% | 48.36% | 37.68% | 18.40% | -- |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 49.08% | 48.36% | 37.68% | 18.40% | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 49.08% | 48.36% | 37.68% | 18.40% | -- |
| EBIT | 48.10% | 47.63% | 35.12% | 14.84% | -- |
| EBITDA | 48.19% | 47.71% | 35.20% | 14.93% | -- |
| EPS Basic | 57.04% | 53.58% | 40.80% | 20.96% | -- |
| Normalized Basic EPS | 55.72% | 52.33% | 37.94% | 16.82% | -- |
| EPS Diluted | 57.04% | 53.58% | 40.80% | 20.96% | -- |
| Normalized Diluted EPS | 55.72% | 52.33% | 37.94% | 16.82% | -- |
| Average Basic Shares Outstanding | 23.56% | 14.66% | 5.40% | 2.60% | -- |
| Average Diluted Shares Outstanding | 23.56% | 14.66% | 5.40% | 2.60% | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |